Again
PrivateLast Round
Series A
Jul 17, 2024
Total Funding Raised
$101.2M
Company Overview
Again operates in Energy & Sustainability and is based in Copenhagen. Its latest recorded funding round was a Series A round in July 2024.
Again is a biotechnology company that utilizes a proprietary gas fermentation process to convert industrial carbon dioxide waste into carbon-negative chemicals.
Sector
Energy & Sustainability
Verticals
Carbon Capture, Biotechnology, Clean Manufacturing, Sustainable Materials, Circular Economy
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Again Comparables
Compare Again with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanjing Gasgene Biochemical Technology Co., Ltd. | 78% | |
| LanzaTech | 78% | |
| Circe Bioscience | 77% |
For institutional investors. Book with your work email.
Again Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 17, 2024 | ||||
| Seed | Nov 28, 2023 | ||||
| Pre Seed | Aug 10, 2022 | ||||
| Grant | Oct 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Again Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HV Capital | Series A |
| GV | Seed, Series A |
| The Export and Investment Fund of Denmark | Series A |
| Atlantic Labs | Series A, Pre Seed, Seed |
| Sherpa Capital | Series A, Seed |
| Atlantic Labs | Series A, Seed, Pre Seed |
| CSC Leasing | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 29, 2026
Grew 17% QoQ, from 65 to 76 employees.
- Nov 1, 2025
Commissioning first CO2-to-acetic acid fermentation plant in Houston.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- acquiresAug 12, 2026
On Aug 12th '26, Again acquires Genomatica in Denmark, combining AI and biomanufacturing capabilities; financial terms are not disclosed.
For institutional investors. Book with your work email.
Again Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Again's valuation, stock price, and market status.
Is Again a public or private company?
Again is a private company.
What is the current stock price of Again?
Again is a private company, so its shares have no public market price. Caplight tracks Again's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Again worth (valuation)?
Valuation information for Again is not publicly available.
Can I buy Again stock?
Again shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Again's last funding round?
Again's most recent funding round was Series A on July 17, 2024.
Who are the main investors in Again?
Key investors in Again include HV Capital, GV, Atlantic Labs.
Will Again IPO soon?
No public IPO plans have been announced for Again.
How can I track Again secondary market activity?
Caplight tracks bids, offers, and trades in Again's shares on secondary markets.